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Protein family review
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Summary
Silent information regulator 2 (Sir2) proteins, or sirtuins, are protein deacetylases dependent on
nicotine adenine dinucleotide (NAD) and are found in organisms ranging from bacteria to
humans. In eukaryotes, sirtuins regulate transcriptional repression, recombination, the cell-
division cycle, microtubule organization, and cellular responses to DNA-damaging agents. Sirtuins
have also been implicated in regulating the molecular mechanisms of aging. The Sir2 catalytic
domain, which is shared among all sirtuins, consists of two distinct domains that bind NAD and
the acetyl-lysine substrate, respectively. In addition to the catalytic domain, eukaryotic sirtuins
contain variable amino- and carboxy-terminal extensions that regulate their subcellular
localizations and catalytic activity. 
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Gene organization and evolutionary history
Protein acetylation regulates a wide variety of cellular func-
tions, including the recognition of DNA by proteins, protein-
protein interactions, and protein stability (reviewed in [1]).
Post-translational modification of proteins at lysine residues
by reversible acetylation is catalyzed by the opposing activities
of histone acetyltransferases (HATs) and histone deacetylases
(HDACs), which act on both histone and non-histone sub-
strates despite their names. HDACs are grouped into three
classes on the basis of their homology to yeast transcriptional
repressors. Class I and class II HDACs, which share significant
similarity to each other in their catalytic cores, are homologs
of the yeast deacetylases Rpd3p and Hda1p, respectively
(reviewed in [2,3]). The class III HDACs are homologous to
the yeast transcriptional repressor Sir2p and have no
sequence similarity to class I and II HDACs; these Sir2 pro-
teins, also called sirtuins, are the focus of this article. 
The founding member of class III HDACs, Saccharomyces
cerevisiae Sir2p, functions in transcriptional repression at
the telomeres [4,5], the silent mating-type loci [6-8], and
ribosomal DNA loci [9,10]. Sir2p has been implicated in the
repair of double-strand DNA breaks, cell-cycle progression,
and chromosomal stability in yeast and plays a pivotal role
in the molecular mechanisms of aging in both S. cerevisiae
and Caenorhabditis elegans [11-15]. 
Sirtuins have been found in bacteria to eukaryotes [16,17]. The
hallmark of the family is a domain of approximately 260
amino acids that has a high degree of sequence similarity in all
sirtuins. The family is divided into five classes (I-IV and U) on
the basis of a phylogenetic analysis of 60 sirtuins from a wide
array of organisms [17] (Figure 1). Class I and class IV are
further divided into three and two subgroups, respectively.
The U-class sirtuins are found only in Gram-positive bacteria
[17]. The S. cerevisiae genome encodes five sirtuins, Sir2p and
four additional proteins termed ‘homologs of sir two’ (Hst1p-
Hst4p) [11] (Figure 1). The human genome encodes seven sir-
tuins, with representatives from classes I-IV (Table 1) [17]. 
Characteristic structural features
The sirtuins have a catalytic domain, unique to this family,
characterized by its requirement for nicotine adenine dinu-
cleotide (NAD) as a cofactor [18]. The structures of four sir-
tuins (Archaeoglobus fulgidus Sir2-Af1 and Sir2-Af2, humanSirt2, and yeast Hst2) have been obtained at atomic resolu-
tion, and a number of common features are emerging [18-
21]. All four are organized in two bilobed globular domains:
a small domain with two distinct modules and a large
domain (Figure 2). 
The large domain 
The large domain contains an inverted classical open /
Rossmann-fold structure, which is commonly found in
proteins that bind oxidized or reduced NAD or NADP
[18,20,21] (Figure 2). This domain consists of six parallel
 strands (1-3 and 7-9) that form a central  sheet, and
eight  helices (1, 2, 6, 7, and 9-12) that pack against
the  sheet (Figure 2). Sirt2 and the yeast Hst2p each have
an additional  helix in the crystal structure, 13, that packs
against the outside of the large domain but is not found in
Sir2-Af1 or Sir2-Af2. The most significant difference in the
large domains is an insertion in the region of the 11 helix
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Figure 1 
An unrooted tree diagram derived from phylogenetic analysis of the conserved domains of 60 sirtuin sequences from all sirtuin classes. Classes I, II, III, IV,
and U and subdivisions of classes I and IV are indicated. Organism abbreviations: A. act, Actinobacillus actinomycetemcomitans; A. aeo, Aquifex aeolicus;
A. ful, Archaeoglobus fulgidus; A. per, Aeropyrum pernix; A. tha, Arabidopsis thaliana; B. per, Bordetella pertussis; B. sub, Bacillus subtilis; C. ace, Clostridium
acetabutylicum; C. alb, Candida albicans; C. dif, Clostridium difficile; C. ele, Caenorhabditis elegans; C. jej, Campylobacter jejuni; D. mel, Drosophila melanogaster;
D. rad, Deinococcus radiodurans; E. col, Escherichia coli; E. fae, Enterococcus faecalis; H. sap, Homo sapiens; H. pyl, Helicobacter pylori; L. maj, Leishmania major;
M. avi, Mycobacterium avium; M. tub, Mycobacterium tuberculosis; O. sat, Oryza sativa; P. aby, Pyrococcus abyssi; P. fal, Plasmodium falciparum; P. hor, Pyrococcus
horikoshii; S. aur, Staphylococcus aureus; S. coe, Streptomyces coelicolor; S. pom, Schizosaccharomyces pombe, S. typ, Salmonella typhimurium; S. cer, Saccharomyces
cerevisiae; T. bru, Trypanosoma brucei; T. mar, Thermotoga maritima; Y. pes, Yersinia pestis. Modified from [17].
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A. thain Sirt2 and Hst2p that is absent from Sir2-Af1 and Sir2-
Af2. This helix is located outside the catalytic pocket but on
the same face; it could possibly have a role in the recogni-
tion of substrate or of other members of a macromolecular
complex [18].
The small domain 
The small domain has two structural modules that result
from two insertions in the Rossmann fold of the large
domain [18,20,21]. The first insertion consists of three
 helices (3,  4, and 5) that fold to form the helical
module (Figure 2). This module has a pocket, lined with
hydrophobic residues, that intersects the large groove
between the small and large domains. The properties of the
pocket suggest that it may be a class-specific protein-protein
interaction domain, possibly recognizing specific residues in
the substrate protein. Sequence alignments show that all
class I sirtuins have the 3I, 3, 4, and 5 helices that form
the hydrophobic pocket, but classes II, III, and IV sirtuins
have deletions in this area, suggesting class-specific differ-
ences. Structural data from Sir2-Af1 bound to NAD, Sir2-Af2
bound to p53, and unbound human Sirt2 suggest that the
helical module undergoes a conformational change upon
binding of NAD, possibly to allow interaction with acetyl-
lysine substrates [21].
The second insertion forms a zinc-binding module (see
Figure 2), composed of antiparallel  strands containing two
Cys-X-X-Cys motifs (where X is any amino acid) separated
by 15-20 amino acids that are involved in zinc coordination
[18,20,21]. Replacing the cysteines with alanines abolishes
enzymatic activity in vitro and the silencing activity in vivo
at silent mating-type, telomeric, and rDNA loci [20,22].
Likewise, the presence of zinc is required for enzymatic
activity, as the zinc chelator o-phenanthroline inhibits
enzymatic activity [20]. The localization of zinc away from
the NAD-binding pocket suggests that the zinc ion does not
participate directly in catalysis. This is in contrast to class I
and class II HDACs, in which zinc ions are part of the active
site [20,23]. 
The NAD-binding pocket 
The NAD-binding pocket, located within the large domain at
the interface of the large and small domains, can be divided
into three spatially distinct regions: the A site, where the
adenine-ribose moiety of NAD is bound, the B site where the
nicotinamide-ribose moiety is bound, and the C site, located
deep in the NAD-binding pocket (see also Figure 3) [20].
The B and C sites are thought to be directly involved in catal-
ysis. In the presence of an acetyl-lysine, NAD bound to the B
site can undergo a conformational change, bringing the
nicotinamide group in proximity to the C site, where it can
be cleaved [20]. The ADP-ribose product of this reaction
may then return to the B site, where deacetylation of the
acetyl-lysine occurs. The organization of the NAD-binding
pocket might explain how nicotinamide inhibits sirtuin
activity. At high concentrations, free nicotinamide may
occupy the C site, irrespective of whether any acetylated
lysine is bound, and block the conformational change of
NAD [24].
The large groove
A large groove is formed at the interface between the large
and small domains and runs perpendicular to the long axis
formed by the two domains (Figure 2). On the basis of muta-
genesis studies, a role in substrate recognition and catalysis
has been proposed for this groove [18,20]. Analysis of the
crystal structure of A. fulgidus Sir2-Af2 complexed with a
p53 peptide (Figure 2b) demonstrates that the peptide sub-
strate lies in the large groove [21]. The binding of an acety-
lated peptide, such as p53, may occur through the formation
of an enzyme-substrate  sheet, in which the substrate
 strand is sandwiched between the 11 strand within the
Rossmann fold and a 10 strand within the FGE loop,
named for its highly conserved FGExL motif [21]. A high
degree of conservation between sirtuins is found in the
residues implicated in substrate peptide binding, specifically
in the region of the FGE loop [21]. The predicted 10 and
11 strands of Sir2-Af2 are absent from the solved structures
of Sirt2, Sir2-Af1, and Hst2p, however. These observations
suggest that these two regions become more ordered and
form the enzyme-substrate  sheet upon substrate binding,
as seen in the Sir2-Af2 p53 structure [21]. 
Amino- and carboxy-terminal extensions
The solved structures of full-length A. fulgidus Sir2-Af1,
A. fulgidus Sir2-Af2 and human Sirt2 correspond primarily
to the catalytic domain found within sirtuins. Yeast Hst2 and
human Sirt2 have large amino- and carboxy-terminal exten-
sions (not shown for Sirt2 in Figure 2c) that are likely to play
a role in the regulation of enzymatic activity. In support of
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Table 1 
Classification and chromosomal locations of human sirtuin
genes
Chromosomal Orthologs
Name Class location OMIM ID Yeast Mouse
Sirt1 Ia 10q21.3 604479 Sir2, Hst1 Sir2
Sirt2 Ib 19q13.2 604480 Hst2 Sir2l2
Sirt3 Ib 11p15.5 604481 Hst2 Sir2l3
Sirt4 II 12q24.31 604482 Sirt4
Sirt5 III 6p23 604483 Sirt5
Sirt6 IVa 19p13.3 606211 Sirt6
Sirt7 IVb 17q25.3 606212 Sirt7
Mouse orthologs of human Sirt4-7 have not been characterized but are
found in sequence databases. OMIM IDs are from the Online Mendelian
Inheritance in Man repository at the National Center for Biotechnology
Information (NCBI) [76].224.4 Genome Biology 2004, Volume 5, Issue 5, Article 224 North and Verdin http://genomebiology.com/2004/5/5/224
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Figure 2
Three-dimensional high-resolution crystal structures of four sirtuin proteins. The zinc-binding module is shown at the top left in each panel, the helical
modules of the small domain are lighter and at the top right, and the large Rossmann-fold domain is in the lower half. Each  helix and  strand is labeled
to facilitate comparisons. (a) Sir2-Af1 complexed with NAD (in stick representation; PDB accession number: 1ICI) [20]. (b) Sir2-Af2 complexed with
acetylated p53 peptide (in stick notation, with acetyl-lysine darker). Two  strands (10 and 11) are shown that might mediate the binding of the
substrate peptide (PDB accession number: IMA3) [21]. An acetylated peptide, such as p53, may be bound through the formation of an enzyme-substrate
 sheet, in which the substrate  strand is sandwiched between the 11 strand within the Rossmann fold and a 10 strand within the FGE loop, named
for its highly conserved FGExL motif [21]. (c) Human Sirt2 (catalytic core; PDB accession number: 1J8F) [18]. (d) Full-length yeast Hst2p with the
carboxy-terminal 14 helix interacting with the NAD-binding pocket (PDB accession number: 1Q14) [19]. Structural coordinates were taken from the
Protein Data Bank and models were drawn with PYMOL [77]. 
(a) Sir2-Af1+NAD
(c) Sirt2
(b) Sir2-Af2+p53
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silencing are affected by various mutations outside the cat-
alytic core [19]. In addition, the structure of full-length yeast
Hst2p indicates that the carboxy-terminal extension folds
into the NAD-binding pocket and that the amino-terminal
extension may occlude the substrate binding cleft [19]. The
carboxy-terminal 14 helix of yeast Hst2p interacts exten-
sively with residues within the large groove between the
large and small catalytic domains of the protein, as well as
with residues in these domains. In the apo (unbound) form
of Hst2p the 14 helix probably partially occludes the cofac-
tor NAD-binding site and the loop following 1 is disor-
dered. NAD binding then promotes dissociation of the 14
helix and ordering of the loop after 1, to facilitate enzymatic
activity. Likewise, the human Hst2p homolog Sirt3 is enzy-
matically inactive as a full-length protein and becomes cat-
alytically active after proteolytic cleavage of its amino
terminus following import in the mitochondrial matrix [25]. 
Localization and function 
Sirtuin proteins have been found in a wide variety of subcel-
lular locations. Human Sirt1 localizes to the nucleus, as does
yeast Sir2p [26]; Sirt1 appears to repress transcription in the
nucleus by various different mechanisms. Human Sirt2 and
Sirt3 localize to extra-nuclear compartments, much like yeast
Hst2p: Sirt2 is found in the cytosol [27,28], whereas Sirt3 is
found primarily in the mitochondria [25,29] (see Figure 4).
A key function of sirtuins is their regulation of transcrip-
tional repression, mediated through binding of a complex
containing sirtuins and other proteins. The silencing func-
tion of the yeast Sir2p is mediated by different multiprotein
complexes at different genomic sites. Silencing at the
telomeres and at the mating-type loci is mediated by a
protein complex consisting of Sir2p and the structurally
unrelated proteins Sir3p and Sir4p. Sequence-specific DNA-
binding proteins mediate the initial recruitment of Sir
protein complexes to the telomeres and mating-type loci. At
those loci, Sir3p and Sir4p blanket the underlying nucleo-
somes by interacting with hypoacetylated tails of histones
H3 and H4, and Sir2p interacts with Sir3p and Sir4p
(reviewed in [30]). Sir2p-dependent silencing of ribosomal
DNA (rDNA) is mediated by the ‘regulator of nucleolar
silencing and telophase exit’ (RENT) complex, containing
Sir2p, Net1p, and a telophase-regulating phosphatase,
Cdc14p, which is released in late metaphase [31,32]. At
rDNA loci, Sir2p can silence transcription of RNA poly-
merase II-dependent marker genes inserted within the
rDNA array and also suppresses homologous recombination
among the tandemly repeated rDNA copies [9,33,34].
Enzyme mechanism
Initial enzymatic experiments with sirtuins, carried out in
the bacterium Salmonella typhimurium, revealed only
their activity as ADP-ribosyltransferases, not protein
deacetylases. During the biosynthesis of cobalamin (also
known as vitamin B12), the CobT enzyme in Salmonella
catalyzes the transfer of phosphoribose from nicotinic acid
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Figure 3 
The enzymatic activity of sirtuins. (a) The components necessary for
sirtuin-mediated deacetylase activity are the sirtuin, -NAD, and the
N-acetylated substrate. (b) The components form a tertiary complex and,
during the enzymatic reaction, the nicotinamide is expelled from bound
NAD to generate an oxocarbonium-like transition state in which the
carbonyl oxygen of the acetyl group attacks the C1 carbon of ADP. After
alkylamidate and cyclic intermediates and possibly protonation of the
amine leaving group (not shown), the products (c) are formed: the
deacetylated protein, 2-O-acetyl-ADP-ribose, and nicotinamide. The
2-O-acetyl-ADP-ribose is released into solution, where it equilibrates
with 3-O-acetyl-ADP-ribose. Adapted with modifications from [78].
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(c)mononucleotide (NaMN) to dimethylbenzimidazole
(DMB) to form DMB-5-ribosyl-phosphate [35,36]. In the
absence of CobT, the Sir2-like protein CobB can partially
compensate in the catalysis of this reaction [37]. In later
studies, recombinant Sir2 proteins from both bacteria and
humans were shown to have NAD-dependent ADP-ribo-
syltransferase activity in vitro [16,38]. 
Although the enzymatic function initially associated with
sirtuins was ADP-ribosyltransferase activity, NAD-
dependent histone-deacetylase activity was subsequently
shown to be the primary enzymatic activity of Sir2p and
other sirtuins [39-41]. The deacetylation reaction gener-
ates three products: acetyl-ADP-ribose, nicotinamide,
and a deacetylated peptide substrate (Figure 3). The ratio
of these products is 1:1:1, consistent with the model that
hydrolysis of one NAD to acetyl-ADP-ribose and nicoti-
namide occurs for each acetyl group removed, and that
deacetylation requires an enzyme-ADP-ribose intermedi-
ate (Figure 3) [42]. The demonstration that the ribosyl-
transferase and NAD-cleavage activities are both
dependent on an acetylated substrate confirms the funda-
mental link between the two activities [38,39,42-44]. The
recent observation that O-acetyl-ADP-ribose delays
oocyte maturation and cell division in blastomere-stage
embryos suggests that this compound might be a bona
fide second messenger linked to the enzymatic activity of
sirtuins [43-45].
It remains likely that there is a physiological role for the
ADP-ribosyltransferase activity of individual sirtuins. A
recently identified Trypanosoma brucei class Ib sirtuin,
TbSIR2RP1, exerts both histone-deacetylase and robust
ADP-ribosyltransferase activity on histones H2A and
H2B [46]. García-Salcedo et al. [46] have suggested that
the activity of TbSIR2RP1 and extent of chromatin ADP
224.6 Genome Biology 2004, Volume 5, Issue 5, Article 224 North and Verdin http://genomebiology.com/2004/5/5/224
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Figure 4
Localization and functions of the human sirtuins Sirt1, Sirt2 and Sirt3. Sirt1 is found in the nucleus; it associates with several partners and targets for
deacetylation, as discussed in the text. Sirt2 is found in the cytoplasm bound to the microtubule network, where it forms a complex with the histone
deacetylase HDAC6. Both proteins can deacetylate -tubulin. Sirt3 is imported into the mitochondrial matrix and proteolytically processed by the
peptidase MPP, leading to its enzymatic activation (asterisk). Ac, acetyl moiety; ProteinX, an unknown protein substrate.
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Sirt1ribosylation correlates with the sensitivity of trypanosomes
to agents that damage DNA.
It is not clear whether all five classes of sirtuins have deacety-
lase activity. For instance, only class I human sirtuins (Sirt1,
Sirt2, and Sirt3) have robust enzymatic activity on a peptide
corresponding to the amino-terminal tail of histone H4 [47].
Sirt5, a class III sirtuin, has low but detectable activity in com-
parison with the class I sirtuins [47]. Interestingly, the class III
sirtuin from A. fulgidus, Sir2-Af1, also has low activity on a
histone peptide but significantly stronger activity on an acety-
lated bovine serum albumin substrate, suggesting that the
level of deacetylase activity is substrate-specific [20,21]. 
Phenotypic screens using yeast strains that have either
URA3 or TRP1 inserted within Sir2p-silenced loci have led to
the identification of -substituted  -naphthol compounds,
sirtinol and splitomicin, which inhibit the enzymatic activity
of Sir2 proteins [48,49]. Sirtinol inhibits recombinant Sir2p
and human Sirt2 in vitro and silencing at the telomeres,
silent mating-type, and rDNA loci in vivo. Sirtinol was
recently used to define further the role of mammalian Sir2
proteins in the regulation of muscle gene expression and dif-
ferentiation in response to alterations in the ratio of concen-
trations of NAD+ and NADH [50].
Other inhibitors have been developed that capitalize on the
dependence of the sirtuins’ enzymatic activity on NAD. A
nonhydrolyzable NAD molecule, carba-NAD, inhibits
sirtuin activity, consistent with the requirement for NAD
cleavage during the enzymatic reaction [42]. It is unlikely,
however, that this inhibitor will prove useful in vivo
because it cannot permeate cells and because of its poten-
tial to affect other cellular NAD-dependent enzymatic
activities or biological pathways [48]. Nicotinamide, a
byproduct of the NAD-dependent deacetylation reaction,
inhibits sirtuins both in vitro and in vivo [42,51,52]. 
A recent study found a number of compounds that increase
the enzymatic activity of sirtuins [53], one of which, resvera-
trol, activates both yeast Sir2p and human Sirt1 in vitro and
in vivo. Plant polyphenols such as resveratrol - which is
found in grapes and red wine - have been associated with
health benefits such as cardioprotection, neuroprotection,
and cancer suppression [54-56]. Sirtuins have been impli-
cated in the regulation of cellular and organismal aging in
several model organisms (see Frontiers); regulation of sirtu-
ins by polyphenols may provide a functional link between
the effects of plant products such as resveratrol on health
and longevity and the regulation of aging [53]. 
Substrates and functions 
The functions and substrates have been studied most for
human Sirt1, Sirt2 and Sirt3 and their closest yeast
homologs Sir2, Hst1 and Hst2; little is known about the
functions of Sirt4, Sirt5, Sirt6, and Sirt7.
Sirt1
TAFI68, a transcription factor necessary for regulation of the
RNA polymerase I transcriptional complex, was the first
substrate to be identified for Sirt1 [57]; the fact that S. cere-
visiae Sir2p also regulates rDNA suggests that Sir2p and
Sirt1 may have similar functions. Deacetylation of TAFI68 by
Sir2 - the mouse ortholog of human Sirt1 - inhibits tran-
scriptional initiation in vitro [57]. Sirt1 is reported to associ-
ate physically with the human basic helix-loop-helix (bHLH)
repressor proteins hHES1 and hHEY2 [58] (Figure 4); a
similar interaction is also found in Drosophila, in which the
bHLH repressor proteins Hairy and Deadpan recruit a
sirtuin protein [59]. The Hairy-related bHLH proteins func-
tion as transcriptional repressors and play important roles in
diverse aspects of metazoan development. Sirt1 has also
been shown to form a complex with the histone acetyltrans-
ferase PCAF and the muscle transcription factor MyoD, and
it deacetylates both proteins [50]. Although transcriptional
regulation by Sirt1 through TAFI68, bHLH, MyoD and
PCAF, and p53 (see below) identify non-histone targets for
the sirtuins, Sirt1 might also regulate histone acetylation
directly through its interaction with sequence-specific DNA
binding factors, such as COUP-TF-interacting proteins 1 and
2 (CTIP1 and CTIP2) or a MyoD/PCAF complex [50,60].
These findings implicate Sirt1 as a transcriptional repressor
that functions through deacetylation of histones and non-
histone proteins. 
Sirt1 deacetylase activity has also been implicated in the
repair of DNA damage, through its ability to deacetylate the
tumor suppressor p53 [26,52], a sequence-specific transcrip-
tion factor that regulates processes such as the cell cycle, cell
death, and DNA repair, in response to a variety of stress
signals. The p53 protein is acetylated at two lysine residues,
Lys320 and Lys382, in response to DNA damage, leading to
its activation [61-63]. Acetylation by the acetyltransferase
p300 positively regulates p53 activity, and deacetylation by
HDAC1 and Sirt1 negatively regulates its activity [26,63].
Sirt1-mediated deacetylation of p53 suppresses the induc-
tion of apoptosis and prolongs cellular survival in response
to DNA damage [52]. Both Sirt1 and p53 can be localized in
promyelocytic leukemia (PML) bodies [51], subnuclear
structures that are altered or disrupted in certain tumors
and in response to various different cellular stresses [64].
These studies [26,51,52,61-63] suggest that Sirt1 deacety-
lates the p53 tumor suppressor protein to dampen apoptotic
and cellular senescence pathways. 
Two studies [65,66] have used gene-targeted mutagenesis
experiments in mice to examine the consequences of
expressing a mutant Sirt1 protein lacking part of the catalytic
domain or of deleting the ortholog of the Sirt1 gene com-
pletely. McBurney et al. [65] showed that animals homozy-
gous for a null allele of sir2 are born at only half the
expected frequency, suggesting prenatal lethality; homozy-
gous embryos and pups are smaller than their wild-type and
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of the eyes, lungs, and pancreas. In an outbred back-
ground, the Sir2-null animals often survive to adulthood,
but both sexes are sterile because of a failure to ovulate in
females and inefficient spermatogenesis in males [65].
Unexpectedly, there is no defect in gene silencing in Sir2-
null animals, nor in Sir2-null homozygous embryonic
stem cells, suggesting either that Sirt1 orthologs have a dif-
ferent role in mammals from that in S. cerevisiae or that
its role in gene silencing is confined to a small subset of
mammalian genes [65,67]. In the second study [66], mice
were generated that lacked Sir2 or expressed a mutant
Sir2 protein lacking part of the catalytic domain. Both
types of Sir2 mutant mice were smaller than their wild-
type and heterozygous littermates and had developmental
defects in the retina and heart; most died postnatally [66].
Sir2-deficient thymocytes showed an increase in p53
hyperacetylation in response to ionizing radiation, fol-
lowed by apoptosis [66]. The phenotype of the Sir2-null
mice suggests that the Sirt1 protein is essential for normal
embryogenesis and for normal reproduction in both sexes
in mammals. Further study of the function of Sirt1
orthologs at the molecular level will help to unravel the
origins of these developmental defects.
Sirt2
The human Sirt2 protein is similar in sequence to yeast
Hst2p and both proteins are located in the cytoplasm
[27,28] (Figure 4), where Hst2p affects chromatin silenc-
ing through an unknown mechanism [27]. Sirt2 colocalizes
with the microtubule network and deacetylates Lys40 of -
tubulin [47]. The same residue of -tubulin is also deacety-
lated by HDAC6, a class II HDAC, and deacetylation by
HDAC6 leads to changes in cellular motility [68]. Sirt2 and
HDAC6 are found along microtubules and can be co-
immunoprecipitated with each other, suggesting that the
two proteins coordinately regulate the level of tubulin
acetylation [47]. Recent evidence shows that Sirt2 is upreg-
ulated before mitosis and suggests a role for this protein in
cell-cycle regulation [69]. Sirt2 is rapidly degraded after
mitosis, and cells overexpressing mutant forms of Sirt2
show a delay in exit from mitosis. Whether Sirt2-depen-
dent regulation of -tubulin acetylation is related to cell-
cycle arrest remains to be determined.
A role for Sirt2 in cancer pathogenesis was recently demon-
strated using a proteomic approach [70]. The Sirt2 gene,
which is located at chromosome 19q13.2, lies within a region
that is frequently deleted in human gliomas, and levels of
Sirt2 mRNA and Sirt2 protein expression are severely
reduced in a large fraction of human glioma cell lines [70].
Ectopic expression of Sirt2 in these cell lines suppressed
colony formation and modified the microtubule network.
These results indicate that Sirt2 may act as a tumor suppres-
sor and may function to control the cell cycle by acetylation
of -tubulin.
Sirt3
Human Sirt3 is primarily located in the mitochondrial
matrix [25,29] (Figure 4), and its mitochondrial import is
mediated by an amphipathic  helix at its amino terminus.
The protein, whether endogenous or overexpressed, is prote-
olytically clipped at its amino terminus in vivo, resulting in
the removal of the first 100 amino acids. This clipping
can be recapitulated in vitro with purified mitochondrial-
matrix processing peptidase (MPP) [25]. Interestingly, the
unprocessed protein is enzymatically inactive in vitro and
becomes enzymatically active after proteolytic processing by
MPP [25]. Negative regulation of the enzymatic activity of a
sirtuin by its amino terminus is also observed in the case of
another class Ib sirtuin, yeast Hst2p. This protein may form a
homotrimer in solution, such that the amino-terminal
methionine of each molecule interacts with the active site in
another Hst2p molecule within the quaternary structure [19]. 
Although Sirt3 shows robust histone deacetylase activity on a
histone H4 peptide in vitro, the absence of histones in mito-
chondria suggest that non-histone proteins are its primary
target [25,29]. Mouse Sirt3, also called Sir2L3, lacks the
amino-terminal extension that mediates the mitochondrial
targeting of human Sirt3 and is located in cytoplasmic vesicles
[71]. Finally, a small fraction of cells overexpressing Sirt3
shows reproducible nuclear staining (B.J.N. and E.V., unpub-
lished observations); the relevance of this observation is
unclear, but it could indicate selective targeting of Sirt3 to dif-
ferent compartments under different physiological conditions. 
Frontiers 
Much excitement has been generated by the recent observa-
tions that sirtuin proteins might play a significant role in the
genetic control of aging. In S. cerevisiae, lifespan is short-
ened by a null mutation in SIR2 and is extended by the pres-
ence of an extra copy of SIR2 [12,72]. Loss of Sir2p leads to a
derepression of silencing at the rDNA locus, which increases
recombination between rDNA repeats and results in the
accumulation of extrachromosomal rDNA circles. High
numbers of these circles in older mother cells promote
senescence by an undefined mechanism, possibly through
the titration of necessary factors away from other promoters
[73]. Likewise, the C. elegans Sir2p homolog, Sir-2.1, medi-
ates dauer-larva formation and regulates lifespan [15]. The
dauer larva represents a specialized survival form of the
worm; the molecular mechanisms by which Sir-2.1 controls
dauer formation remain to be elucidated, however.
It has been speculated that the metabolic rate of the cell
may be important in the regulation of the function of
various sirtuins, given their dependency on NAD for enzy-
matic activity. This idea is further supported by evidence
that NAD metabolism directly participates in controlling
the aging process [12,74,75]. Translating these ideas to
mouse and human sirtuins could give novel insights into the
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be a key part of the decision of a cell whether to live or die in
response to DNA damage. As the cell ages and NAD levels
become lower, the resulting reduced activity of Sirt1 could
drive the decision to cell senescence or apoptosis rather than
cellular survival. Likewise, lowered activity of Sirt2 via
reduced levels of NAD could alter the rate of cell division
through cell-cycle regulation. The localization pattern of
Sirt3 in the mitochondrial matrix and its dependence on
NAD suggest a possible function in the regulation of cellular
metabolism as a sensor for intramitochondrial NAD levels.
Further work is required to determine the endogenous target
of this deacetylase in the mitochondrial compartment,
however. Genetic deletion of the genes encoding different
sirtuins in mice will facilitate studies of their roles in mam-
malian aging.
In addition to a connection between metabolism and sirtuin
activity via NAD, the formation of O-acetyl-ADP-ribose as an
enzymatic byproduct represents another promising area of
investigation. Microinjection of O-acetyl-ADP-ribose delays
or blocks oocyte maturation and cell division in blastomeres
[45]. A similar effect is observed after microinjection of low
levels of active yeast Hst2 or human Sirt2 enzyme, but not
with a catalytically impaired mutant, indicating that the
enzymatic activity is essential for the observed effects. 
Human Sirt4, Sirt5, Sirt6, and Sirt7 show low or unde-
tectable enzymatic activity on histone H4 peptide [47]. This
could reflect differing substrate specificities or different
requirements for cofactors, a field of investigation that is
likely to yield interesting insights in the future. Finally, an
increased understanding of the relationship between the
structure and function of sirtuin proteins will be important
in designing specific inhibitors and exploring their potential
therapeutic value in a variety of pathological conditions. 
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